These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 27099137)

  • 1. Morphine delays the onset of action of prasugrel in patients with prior history of ST-elevation myocardial infarction.
    Thomas MR; Morton AC; Hossain R; Chen B; Luo L; Shahari NN; Hua P; Beniston RG; Judge HM; Storey RF
    Thromb Haemost; 2016 Jul; 116(1):96-102. PubMed ID: 27099137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crushed Prasugrel Tablets in Patients With STEMI Undergoing Primary Percutaneous Coronary Intervention: The CRUSH Study.
    Rollini F; Franchi F; Hu J; Kureti M; Aggarwal N; Durairaj A; Park Y; Seawell M; Cox-Alomar P; Zenni MM; Guzman LA; Suryadevara S; Antoun P; Bass TA; Angiolillo DJ
    J Am Coll Cardiol; 2016 May; 67(17):1994-2004. PubMed ID: 27012781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of prasugrel administration immediately after percutaneous coronary intervention in ST-elevation myocardial infarction.
    Flierl U; Zauner F; Sieweke JT; Berliner C; Napp LC; Tillmanns J; Bauersachs J; Schäfer A
    Thromb Haemost; 2017 Jan; 117(1):99-104. PubMed ID: 27734075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphine interaction with prasugrel: a double-blind, cross-over trial in healthy volunteers.
    Hobl EL; Reiter B; Schoergenhofer C; Schwameis M; Derhaschnig U; Lang IM; Stimpfl T; Jilma B
    Clin Res Cardiol; 2016 Apr; 105(4):349-55. PubMed ID: 26493304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of intravenous fentanyl compared with morphine on ticagrelor absorption and platelet inhibition in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: rationale and design of the PERSEUS randomized trial.
    Degrauwe S; Roffi M; Lauriers N; Muller O; Masci PG; Valgimigli M; Iglesias JF
    Eur Heart J Cardiovasc Pharmacother; 2019 Jul; 5(3):158-163. PubMed ID: 30101278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immediate response to prasugrel loading in patients with ST-elevation myocardial infarction: Predictors and outcome.
    Koifman E; Beigel R; Herscovici R; Fefer P; Rozenberg N; Sabbag A; Biton Y; Segev A; Shechter M; Asher E; Matetzky S
    Thromb Res; 2016 Aug; 144():176-81. PubMed ID: 27386796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet effect of prasugrel and ticagrelor in patients with ST-segment elevation myocardial infarction.
    Kerneis M; Silvain J; Abtan J; Hauguel M; Barthélémy O; Payot L; Brugier D; Galier S; Collet JP; Montalescot G
    Arch Cardiovasc Dis; 2015 Oct; 108(10):502-10. PubMed ID: 26113480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P2Y12 receptor inhibition and effect of morphine in patients undergoing primary PCI for ST-segment elevation myocardial infarction. The PRIVATE-ATLANTIC study.
    Silvain J; Storey RF; Cayla G; Esteve JB; Dillinger JG; Rousseau H; Tsatsaris A; Baradat C; Salhi N; Hamm CW; Lapostolle F; Lassen JF; Collet JP; Ten Berg JM; Van't Hof AW; Montalescot G
    Thromb Haemost; 2016 Aug; 116(2):369-78. PubMed ID: 27196998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphine is associated with a delayed activity of oral antiplatelet agents in patients with ST-elevation acute myocardial infarction undergoing primary percutaneous coronary intervention.
    Parodi G; Bellandi B; Xanthopoulou I; Capranzano P; Capodanno D; Valenti R; Stavrou K; Migliorini A; Antoniucci D; Tamburino C; Alexopoulos D
    Circ Cardiovasc Interv; 2015 Jan; 8(1):. PubMed ID: 25552565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacodynamic Effects of Pre-Hospital Administered Crushed Prasugrel in Patients With ST-Segment Elevation Myocardial Infarction.
    Vogel RF; Delewi R; Angiolillo DJ; Wilschut JM; Lemmert ME; Diletti R; van Vliet R; van der Waarden NWPL; Nuis RJ; Paradies V; Alexopoulos D; Zijlstra F; Montalescot G; Krucoff MW; van Mieghem NM; Smits PC; Vlachojannis GJ
    JACC Cardiovasc Interv; 2021 Jun; 14(12):1323-1333. PubMed ID: 34167672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet inhibition after loading dose of prasugrel in patients with ST-elevation and non-ST-elevation acute coronary syndrome.
    Wakabayashi S; Kitahara H; Nishi T; Sugimoto K; Nakayama T; Fujimoto Y; Ariyoshi N; Kobayashi Y
    Cardiovasc Interv Ther; 2018 Jul; 33(3):239-246. PubMed ID: 28608310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacodynamic Assessment of Platelet Reactivity After a Loading Dose of Prasugrel or Clopidogrel in Patients With ST-Segment Elevation Myocardial Infarction.
    Ichikawa S; Tsukahara K; Minamimoto Y; Kimura Y; Matsuzawa Y; Maejima N; Iwahashi N; Hibi K; Kosuge M; Ebina T; Kimura K
    Circ J; 2016 Nov; 80(12):2520-2527. PubMed ID: 27725493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-blind, randomized, prospective comparison of loading doses of 600 mg clopidogrel versus 60 mg prasugrel in patients with acute ST-segment elevation myocardial infarction scheduled for primary percutaneous intervention: the ETAMI trial (early thienopyridine treatment to improve primary PCI in patients with acute myocardial infarction).
    Zeymer U; Mochmann HC; Mark B; Arntz HR; Thiele H; Diller F; Montalescot G; Zahn R
    JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt B):147-154. PubMed ID: 25616919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time-dependent benefits of pre-treatment with new oral P2Y
    Pepe M; Cafaro A; Paradies V; Signore N; Addabbo F; Bortone AS; Navarese EP; Contegiacomo G; Forleo C; Bartolomucci F; Di Cillo O; Bianchi FP; Zanna D; Favale S
    Catheter Cardiovasc Interv; 2019 Mar; 93(4):592-601. PubMed ID: 30269413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cangrelor, Tirofiban, and Chewed or Standard Prasugrel Regimens in Patients With ST-Segment-Elevation Myocardial Infarction: Primary Results of the FABOLUS-FASTER Trial.
    Gargiulo G; Esposito G; Avvedimento M; Nagler M; Minuz P; Campo G; Gragnano F; Manavifar N; Piccolo R; Tebaldi M; Cirillo P; Hunziker L; Vranckx P; Leonardi S; Heg D; Windecker S; Valgimigli M
    Circulation; 2020 Aug; 142(5):441-454. PubMed ID: 32795098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VERifyNow in DIabetes high-on-treatment platelet reactivity: a pharmacodynamic study on switching from clopidogrel to prasugrel.
    Cubero Gómez JM; Acosta Martínez J; Mendias Benítez C; Díaz De La Llera LS; Fernández-Quero M; Guisado Rasco A; Villa Gil-Ortega M; Sánchez González Á
    Acta Cardiol; 2015 Dec; 70(6):728-34. PubMed ID: 26717223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized assessment of ticagrelor versus prasugrel antiplatelet effects in patients with ST-segment-elevation myocardial infarction.
    Alexopoulos D; Xanthopoulou I; Gkizas V; Kassimis G; Theodoropoulos KC; Makris G; Koutsogiannis N; Damelou A; Tsigkas G; Davlouros P; Hahalis G
    Circ Cardiovasc Interv; 2012 Dec; 5(6):797-804. PubMed ID: 23169985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COMPARison of pre-hospital CRUSHed vs. uncrushed Prasugrel tablets in patients with STEMI undergoing primary percutaneous coronary interventions: Rationale and design of the COMPARE CRUSH trial.
    Vlachojannis GJ; Vogel RF; Wilschut JM; Lemmert ME; Delewi R; Diletti R; van Vliet R; van der Waarden N; Nuis RJ; Paradies V; Alexopoulos D; Zijlstra F; Montalescot G; Angiolillo DJ; Krucoff MW; Van Mieghem NM; Smits PC
    Am Heart J; 2020 Jun; 224():10-16. PubMed ID: 32272255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P2Y
    Guimarães LF; Généreux P; Silveira D; Pesaro AE; Falcão F; Barbosa BR; de Souza CF; Fonseca FA; Alves CM; Carvalho AC; Stone GW; Caixeta A
    Int J Cardiol; 2017 Mar; 230():204-208. PubMed ID: 28062136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High platelet reactivity on aspirin in patients with acute ST elevation myocardial infarction.
    Dillinger JG; Saeed A; Spagnoli V; Sollier CB; Sideris G; Silberman SM; Voicu S; Drouet L; Henry P
    Thromb Res; 2016 Aug; 144():56-61. PubMed ID: 27289074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.